Drug Type TCR-T Cell therapy |
Synonyms- |
Target |
Action modulators |
Mechanism CTAG1B modulators(cancer/testis antigen 1B modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Esophageal Carcinoma | Preclinical | - | 21 Apr 2026 | |
| Esophageal Carcinoma | Preclinical | - | 21 Apr 2026 |





